Skip to main content

Table 8 Lack of association between the baseline DS3 bone domain score and composite attainment of therapeutic goals

From: Patients with type 1 Gaucher disease in South Florida, USA: demographics, genotypes, disease severity and treatment outcomes

Therapeutic goals attained Number of patients Mean DS3 score (SD) 95% Confidence interval ANOVA P value
Intact spleen pts (N = 45)     0.508
6 of 6 14 2.70 (1.60) 1.86--3.54  
5 of 6 21 3.01 (1.71) 2.28--3.74  
4 of 6 10 2.23 (1.97) 1.01--4.20  
Splenectomy pts (N = 15)     0.282
5 of 5 6 4.26 (2.33) 2.40--6.12  
4 of 5 5 5.82 (1.03) 4.92--6.72  
3 of 5 3 6.08 (1.28) 4.63--7.53